Home/Filings/4/0001104659-24-130521
4//SEC Filing

Taylor Andrew Lawrence 4

Accession 0001104659-24-130521

CIK 0001814114other

Filed

Dec 19, 7:00 PM ET

Accepted

Dec 20, 8:30 AM ET

Size

5.3 KB

Accession

0001104659-24-130521

Insider Transaction Report

Form 4
Period: 2024-12-19
Taylor Andrew Lawrence
Chief Financial Officer
Transactions
  • Purchase

    Common Stock, par value $0.0001 per share

    2024-12-19$4.83/sh+1,000$4,830344,960 total
Footnotes (1)
  • [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.81 to $4.89. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Issuer

Orchestra BioMed Holdings, Inc.

CIK 0001814114

Entity typeother

Related Parties

1
  • filerCIK 0001723889

Filing Metadata

Form type
4
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 8:30 AM ET
Size
5.3 KB